Legal & General Group’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.59M Sell
80,280
-61,465
-43% -$5.81M ﹤0.01% 1344
2025
Q1
$8.99M Sell
141,745
-1,471
-1% -$93.3K ﹤0.01% 1189
2024
Q4
$6.66M Sell
143,216
-234,788
-62% -$10.9M ﹤0.01% 1418
2024
Q3
$10.9M Sell
378,004
-6,204
-2% -$179K ﹤0.01% 1135
2024
Q2
$5.56M Buy
384,208
+304,635
+383% +$4.41M ﹤0.01% 1473
2024
Q1
$1.28M Sell
79,573
-941
-1% -$15.1K ﹤0.01% 2109
2023
Q4
$1.6M Buy
80,514
+12,664
+19% +$252K ﹤0.01% 2051
2023
Q3
$1.11M Buy
67,850
+6,850
+11% +$112K ﹤0.01% 2156
2023
Q2
$1.29M Buy
61,000
+36,624
+150% +$774K ﹤0.01% 2107
2023
Q1
$490K Sell
24,376
-277
-1% -$5.57K ﹤0.01% 2318
2022
Q4
$644K Buy
+24,653
New +$644K ﹤0.01% 2272